All Articles from VOLCANO CORPORATION -Optical Coherence Tomography News

Articles from VOLCANO CORPORATION

1-8 of 8
1. Volcano Corporation Schedules First Quarter Conference Call, Webcast
  
  Explore Volcano Corporation Apr 26 2013 Cardiology , Other Business News
  
  Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the first quarter of fiscal 2013 on Thursday, May 2 . The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Daylight Time ( 5 p.m., Eastern Daylight Time ), Thursday, May 2 , hosted by Scott Huennekens , president and chief executive officer, and John Dahldorf , chief financial officer. The teleconference can ...
  Read Full Article
  
  Comment
  
  Mentions: Scott Huennekens Volcano Corporation John Dahldorf
2. Volcano Corporation Announces Webcast Of March Seventh Analyst Day
  
  Explore Volcano Corporation Feb 26 2013 Cardiology , Other Business News
  
  olcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, will hold its 2013 Analyst Day on Thursday, March 7 , at the NASDAQ MarketSite in New York City . A webcast of the event will begin at 10 a.m., Eastern Standard Time ( 7 a.m., Pacific Standard Time ) and conclude at approximately 2 p.m., Eastern Standard Time ( 11 a.m., Pacific Standard Time ). The webcast of the event will be available through Volcano's website on the webcasts and presentations page of ...
  Read Full Article
  
  Comment
3. Volcano Corporation Announces Record Preliminary Fourth Quarter 2012 Revenues
  
  Explore Volcano Corporation Jan 7 2013 Cardiology
  
  Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it expects total revenues for the fourth quarter of 2012 will be approximately $102.5 million , bringing expected full year 2012 revenues to approximately $381.9 million . Medical segment revenues in the fourth quarter of 2012 increased approximately 10 percent on a reported basis and 12 percent on a constant currency basis versus the fourth quarter of 2011, driven by an increase in FFR (Fractional Flow Reserve) disposable revenues of ...
  Read Full Article
  
  Comment
  
  Mentions: Scott Huennekens Volcano Corporation
4. Volcano Corporation Prices Offering Of $400 Million 1.75% Convertible Senior Notes Due 2017
  
  Explore PR Newswire Dec 5 2012 Funding , Other Business News
  
  Volcano Corporation (NASDAQ: VOLC ) today announced the pricing of its public offering of $400 million aggregate principal amount of 1.75% convertible senior notes due December 1, 2017 registered under the Securities Act of 1933, as amended. Prior to August 7, 2017 , the notes will be convertible only upon certain circumstances and during certain periods. Upon conversion, holders will receive up to the principal amount of the notes in cash and any excess conversion value in shares of Volcano's common stock. Volcano granted the underwriters of the offering a 13-day option to purchase up to $60 million aggregate principal ...
  Read Full Article
  
  Comment
  
  Mentions: Volcano Corporation
5. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
  
  Explore Volcano Corporation Oct 28 2012 Cardiology , Other Business News
  
  Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the third quarter of fiscal 2012 on Tuesday, November 6 . The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time ( 5 p.m., Eastern Standard Time ), Tuesday, November 6 , hosted by Scott Huennekens , president and chief executive officer, and John Dahldorf , chief financial officer. The teleconference can ...
  Read Full Article
  
  Comment
  
  Mentions: Scott Huennekens Volcano Corporation John Dahldorf
6. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
  
  Explore Volcano Corporation Oct 25 2012 Cardiology , Other Business News , Patents
  
  Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that St. Jude Medical agreed that previous versions of its PressureWire® products infringed Volcano's 6,976,965 patent (a pressure sensing guide wire patent). Proceedings on damages have not yet been scheduled. In addition, a jury in the federal district court in Delaware has issued a verdict in St. Jude Medical's favor with respect to Volcano's patents at issue in the Company's ongoing patent lawsuit with St ...
  Read Full Article
  
  Comment
  
  Mentions: Volcano Corporation St. Jude Medical
7. Volcano Corporation Announces Preliminary Fourth Quarter 2011 Revenues
  
  Explore Volcano Corporation Jan 9 2012 Cardiology , Other Business News
  
  SAN DIEGO, Jan. 9, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral artery disease, said today it expects total revenues for the fourth quarter of 2011 will be approximately $92.7 million, bringing expected full year 2011 revenues to approximately $343.5 million. The expectations for revenues in the fourth quarter of 2011 reflect an increase of approximately 14 percent versus revenues of $81.2 million in the fourth quarter a year ago. Medical segment revenues increased approximately 20 percent ...
  Read Full Article
  
  Comment
  
  Mentions: Volcano Corporation
8. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
  
  Explore Optical Coherence Tomography News Feb 10 2011 Cardiology , Other Business News
  
  Volcano Press Release - The Superior Court of Massachusetts entered a Final Judgment today incorporating the Court's earlier rulings rejecting the claims of LightLab Imaging that either Volcano Corporation (www.volcanocorp.com) or its wholly owned subsidiary Axsun Technologies, Inc. used LightLab trade secret information in the development of the Volcano Optical Coherence Tomography ("OCT") System or the Axsun OCT laser. LightLab is an indirect wholly-owned subsidiary of St. Jude Medical, Inc. "After two-plus years of litigation, we are gratified by the Court's decision. Neither Volcano nor Axsun used any of LightLab's purported trade secrets in Volcano's ...
  Read Full Article
  
  Comment
  
  Mentions: Axsun Technologies Scott Huennekens Volcano Corporation
1-8 of 8